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A R T I C L E  I N F O A B S T R A C T
Article type:Original article Objective(s): The present study sought to evaluate the beneficial effects of histidine (His) on oxidative stress, tumor necrosis factor alpha (TNF-α), renal histological alterations and anti-oxidant enzymes 
gene expressions in type 2 diabetic rats.
Materials and Methods: Streptozotocin/nicotinamide (STZ/NA) induced diabetic rats were used as 
an animal model of type 2 diabetes. One group of rats received daily His (1000 mg/l) in drinking 
water for 8 weeks, whereas other groups (control and untreated diabetic groups) received only water. 
Different parameters such as glucose, insulin, insulin resistance, lipid profile, cardiac risk ratios, renal 
functional markers, and oxidative stress were determined in all groups. Moreover, renal histological 
alterations, mRNA expressions of anti-oxidant enzymes, and TNF-α were evaluated in the rats.
Results: His exhibited a protective effect on glucose, insulin, insulin resistance, lipid profile, cardiac 
risk ratios, renal functional markers, oxidative stress, and TNF-α. Furthermore, His restored the 
renal histological alterations and normalized the augmented mRNA expressions of renal anti-oxidant 
enzymes (glutathione peroxidase (GPX) and Cu-Zn superoxide dismutase (Cu-Zn SOD)) and TNF-α.
Conclusion: His could ameliorate diabetes complications related to oxidative stress, inflammation, 
dyslipidemia, hyperglycemia, insulin resistance, and nephropathy. Hence, the use of this amino acid is recommended for diabetic patients in order to reduce diabetes complications.
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IntroductionAs a metabolic disorder, Type 2 diabetes mellitus 
(T2D) is one of the most significant global health problems. About 382 million people suffered from 
T2D in 2013. The number of people affected by T2D 
is estimated to reach 592 million in 2035. The most 
common type of diabetes mellitus (DM) is T2D, which is illustrated by diminished secretion of insulin, insulin 
resistance, and β-cell dysfunction. Thirst, polyuria, 
and fatigue are the most common clinical signs of this 
disease (1-3).
Various organs and tissues are impaired by 
hyperglycemia. Hyperglycemia induces mitochondrial 
dysfunction through the increment of nicotinamide 
adenine dinucleotide (NADH) and Flavin adenine 
dinucleotide (FADH2) levels and prevents proton 
receiving by complex III. These events subsequently 
lead to reactive oxygen species (ROS) generation and 
increase oxidative stress (4, 5). ROS can ultimately 
cause cellular apoptosis and tissue destructions through 
their ability to damage biomolecules, including DNA, 
lipids, and proteins (6). On the other hand, high levels 
of glucose also trigger cellular damages through direct reactions with macromolecules. The increment of lipid 
peroxidation and the glycation of anti-oxidant enzymes 
disrupt the anti-oxidant system (7-10). Furthermore, it 
has been proposed that hyperglycemia contributes to the 
development of inflammation. Inflammatory cytokines 
such as TNF-α play a major role in insulin resistance. Likewise, they are involved in diabetic complications 
such as diabetic nephropathy (11-13). Nevertheless, the application of compounds with anti-oxidant and anti-
inflammatory characteristics seems to be an efficient 
strategy to counteract diabetic injuries. In recent years, 
researches have focused on the significance of amino 
acids in preventing DM complications (14, 15).
Histidine (His) is a semi-essential amino acid in the 
body capable of having different roles such as acting 
as a buffer, binding to divalent metal ions, reducing 
insulin resistance, and scavenging of free radicals. His 
also has anti-oxidant, anti-inflammatory, anti-glycation, 
and anti-lipid peroxidation properties (16-19). It has 
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been demonstrated that the low level of His is related to 
increased inflammation and oxidative stress in chronic 
kidney diseases (20). A review of the previous studies indicates that some researchers have found decreased plasma His in diabetic mice compared with the controls 
(19). Due to the important role of increased oxidative stress 
and inflammation in the pathophysiology of DM and the valuable properties of His in the inhibition of oxidative 
damages, glycation, and reduction of insulin resistance, this study was carried out to evaluate the effects of His 
on oxidative stress biomarkers, lipid profile, cardiac 
risk ratios, insulin, insulin resistance (HOMA-IR), renal 
histological alterations, and the renal gene expressions 
of anti-oxidant enzymes and TNF-α in Wistar rats with 
streptozotocin/nicotinamide (STZ/NA)-induced T2D.
Materials and Methods
Chemicals
STZ, NA, and L-Histidine were purchased from Sigma 
Aldrich Company (USA). Tris-Ethylenediaminetetraacetic 
acid (Tris-EDTA), Tris-Hcl and EDTA were obtained 
from Merck Company (Germany). Commercial kits for 
the evaluation of fasting blood sugar (FBS), triglyceride 
(TG), cholesterol (Chol), high density lipoprotein 
cholesterol (HDL-C), uric acid (UA), and creatinine (Cr) 
were purchased from Pars Azmoon Company (Tehran, 
Iran). Also, Asanzol (Trizol) reagent and commercial kits for the biochemical assessment of malondialdehyde 
(MDA), glutathione (GSH), catalase (CAT), glutathione 
peroxidase (GPX), total superoxide dismutase (SOD), 
nitric oxide (NO), and myeloperoxidase (MPO) were 
purchased from Aryagen Sobhan Azma Novin (Asan) 
Company (Khorramabad, Iran).
Animals and experimental design 
Thirty adult male Wistar rats (180–200 g) were procured from Razi Herbal Medicines Research Center, Lorestan, Iran. The rats were housed in a room with 
standard conditions for laboratory animals including 23±2 °C temperature, humidity of 45% to 55% and 12 
hr light/dark cycle. The animals had free access to food 
pellets except when starvation was required. Moreover, water was provided ad libitum. These conditions were provided for the animals at the animal lab of Razi Herbal Medicines Research Center, Lorestan, Iran. All of our 
experimental procedures and stages of the assessments were performed in conformity with the Research Ethics Committee of the University and Iranian Ethical Guidelines for the Application of Animals in Research. This study also was accepted by the Animal Ethics Committee of Lorestan University of Medical Sciences. Furthermore, our study protocols were in accordance with the methods admitted by the National Institutes of 
Health (NIH1978). 
The rats were haphazardly divided into three groups 
(n=10): control group, untreated diabetic (UTD) group, 
and His-treated diabetic (HTD) group. The rats in the HTD 
group received daily His (1000 mg/l) (19) in drinking water for 8 weeks after the induction of diabetes.
Induction of T2DFor induction of T2D, the animals in the UTD and 
HTD groups were fasted for 12 hr, while they had free 
access to water. Nicotinamide (110 mg/Kg, soluble in 
normal saline) was intraperitoneally injected after the 
fasting period. The intraperitoneal injection of STZ 
(65 mg/kg, soluble in citrate buffer (0.05M, pH=4.5)) 
was accomplished fifteen min after NA injection (21). 
The induction of hyperglycemia was approved by the measurement of FBS in the blood collected from the tail vein of the rats on the third day after the STZ injection. 
The animals with an FBS level of more than 250 mg/dl were considered diabetic rats; hence, they were 
selected for the study (22). The measurement of FBS 
was performed using a glucometer (Accu Chek Active, 
Germany).
Sample collection 
At the end of the eight-week treatment period, 
the animals in each group were anesthetized by intraperitoneal injection of ketamine and xylazine (13 
mg/kg and 87 mg/kg, respectively). Subsequently, blood samples were collected from the animals’ hearts. To clot the blood, the collected blood samples were 
stored at normal room temperature for 20 min. For the separation of serum, the collected blood samples were 
instantaneously centrifuged at 3000 rpm for 15 min (4 °C). The serum samples were poured into microtubes 
and kept at -20 °C until the time of serum biochemical evaluations. Moreover, the livers and kidneys of the 
animals were removed. The right kidney was divided 
into 2 equal parts. One part of the right kidney and the 
liver were immediately homogenized for biochemical 
measurements. Another part of the right kidney was 
kept at -70 °C to be used for molecular evaluation 
and gene expression study. The left kidney was fixed 
in formaldehyde solution (10%) for histological evaluations. 
Biochemical study
The measurement of FBS, insulin, insulin resistance, lipid 
profile, and cardiac risk ratios
The serum levels of FBS, TG, Chol, and high HDL-C were measured by a biochemical auto analyzer 
(Olympus AU-600, Tokyo, Japan) utilizing commercial 
kits (Pars Azmoon, Tehran, Iran). 
The levels of low density lipoprotein (LDL) and very 
low density lipoprotein (VLDL) were determined by the 
equation proposed by Friedewald et al. (23). Moreover, 
cardiac risk ratio 1 (CRR 1): (TC/HDL-C) and CRR 2: 
(LDL/HDL-C) were calculated by the equation proposed 
by Ikewuchi (24). The serum level of insulin was measured by enzyme 
linked immunosorbent assays (ELIZA) technique using the rat insulin kit based on the manufacturer’s protocol 
(Mercodia AB, Sylveniusgatan 8A SE-754 50 Uppsala, 
Sweden). HOMA-IR, as the marker of insulin resistance, 
was calculated using the equation below:  
HOMA-IR=[(fasting insulin (U/ml)×fasting glucose 
[mM]) /22.5].
The measurement of renal functional markers
The levels of renal functional markers, including UA and Cr, in the sera of animals, were determined by 
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a biochemical auto analyzer utilizing commercial kits 
(Pars Azmoon, Tehran, Iran).  
The Evaluation of oxidative stress biomarkersThe concentrations of MDA, GSH, and NO and the 
activities of CAT, GPX, total SOD, and MPO in the serum, the kidneys, and livers of the animals were determined by colorimetrical commercial biochemical kits (Asan, 
Khorramabad, Iran).
Gene expression study
Total RNA isolation and complementary DNA (cDNA) 
synthesis  
In this study, the gene expression of TNF-α and anti-
oxidant enzymes, including Cu-Zn SOD and GPX, were 
evaluated by real-time quantitative PCR in the kidneys 
of rats. Total RNA isolation was carried out according to 
the following steps:
The small part of each frozen kidney sample (100-
150 mg) was placed in the microtube containing 
Asanzol (Trizol) reagent (Asan Company, Khorramabad, 
Iran). Subsequently, the sample was homogenized by an 
ultrasonic homogenizer (HIELSHER UP 200H, Germany). 
The homogenized tissue was incubated at 25 °C (5 min). 
Then, chloroform in the volume of 200 ml was appended 
to the microtube and subsequently centrifuged for 15 
min (12000× g, 4 °C). 250 µl of the upper phase was transmitted to another sterile microtube. In the next 
step following the appending of isopropyl alcohol (250 
µl), the RNA was precipitated by centrifugation for 15 
min (12000× g, 4 °C). RNA precipitations were washed 
with ethanol (75%) by centrifugation for 5 min (7500× 
g, 4 °C). After washing, the precipitations were dried in the air under sterile conditions. RNA precipitations were resuspended in diethyl pyrocarbonate-H2O (DEPC-H2O).The purity and concentration of RNA precipitation 
were specified at 260 and 280 nm by a NanoDrop 
spectrophotometer (Biochrom WPA Biowave II, UK). 
The integrity of isolated RNA was assessed by gel electrophoresis. The conversion of isolated RNA to 
cDNA was executed using Yekta Tajhiz Azma (YTA) 
cDNA Synthesis Kit (YT4500, Iran) according to the 
manufacturer’s guidelines.
Real-time polymerase chain reaction (Real-time PCR)
Real time quantitative PCR was conducted in order 
to reveal the gene expression levels of GPX, Cu-Zn SOD, and TNF-α in the kidneys via Yekta Tajhiz Azma (YTA) 
SYBER Green qPCR Master Mix 2x (YT2551, Iran). The 
reaction was implemented using Rotor-Gene 6000 
(Corbett Research). The final volume of each reaction 
was 20 µl containing Master Mix (10 µl), cDNA (1 µl), 
specific forward & reverse primers (0.8 µl; Sinaclon, 
Iran), and distilled water (8.2 µl). 
The sequence of utilized primers (Table 1) for each 
gene was determined based on the data available in the public database of the Gene Bank of the National Center 
for Biotechnology Information (NCBI). All reactions 
were executed in triplicate. Thermal cycling conditions were provided as follows: 1 cycle of 95 °C for 3 min and 
40 cycles of 95 °C for 5 sec (denaturation), and 40 cycles 
of 60 °C for 20 sec (annealing & extension). β-actin was 
used as the housekeeping gene in this study in order 
to normalize the data. Negative controls without cDNA were used in all reactions. The standardization curve 
was structured by drawing the threshold cycle versus 
serial dilution made of control cDNAs. Product length 
and the specificity of reaction were examined by agarose 
gel electrophoresis (1%). 
Histological assessment   
The kidney samples were processed after their fixation 
in formaldehyde solution (10%). The preparation of the 
paraffin blocks was performed after tissue processing. 
Prepared paraffin blocks were randomly cut into sections 
with 5 μm thickness and stained by periodic Acid-Schiff 
(PAS). Mean glomerular volume was measured through 
a digital procedure equipped with motic camera, motic 
microscope, and the motic image plus software program 
(version 2). The method of Weibel and Gomez was used 
for calculation of the mean glomerular volume (VG). 
VG= area 1.5×1.38/1.01. The numbers 1.38 and 1.01 
represent the shape coefficient and the coefficient size 
distribution, respectively (25).   
Table 1. Primer sequences for Cu-Zn SOD, GPX, TNF-α, and β-actin
 
1 
 
Gene Primers position Primers sequences(5'→3') Product size 
SOD 
(Cu-Zn) 
Forward TTCGAGCAGAAGGCAAGCGGTGAA 
387 
Reverse AATCCCAATCACACCACAAGCCAA 
GPX 
Forward GGTGTTCCAGTGCGCAGAT 
290 
Reverse AGGGCTTCTATATCGGGTTCGA 
TNF-α 
Forward CCGATTTGCCATTTCATACC 
202 
Reverse GAGTCCGGGCAGGTCTACTT 
β-actin 
Forward AGCACTGTGTTGGCATAGAGG 
150 
Reverse TATCGGCAATGAGCGGTTCC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Cu-Zn) SOD: Cu-Zn Superoxide Dismutase, GPX: Glutathione Peroxidase, TNF-α: Tumor Necrosis Factor Alpha,  β-actin: Beta-actin
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Glomerulosclerosis intensity was investigated 
semiquantitatively by a skilled histologist in a blinded manner. The intensity of each section was determined 
by considering a score (0-4) for each glomerulus based 
on the tuft indicating sclerosis: 0=normal glomeruli, 
1=0-25% injury, 2=25%–50% injury, 3=50%–75% injury, and 4= over 75% injury. In the stained tissue, 
sections of each group ≥150 glomeruli were evaluated 
in this assessment (26).
The evaluation of leukocyte infiltration was similar to 
our previous study (27). 
Statistical analysisThe results were illustrated by mean±SEM. The 
biochemical and histological evaluations were separately 
analyzed by one-way analysis of variance (ANOVA). 
Post hoc LSD test was used in order to determine the 
significant differences between the groups. Real-time 
PCR outputs were analyzed by rest-RG software. The 
level of statistical significance was set at P-value<0.05.
Results
Biochemical results As represented in Table 2, the levels of FBS and 
HOMA-IR were significantly (2.74-fold and 2.40-fold, 
respectively) higher in the UTD group compared with 
the control group (P<0.001), while the level of insulin 
(1.22-fold) was remarkably lower in the UTD group 
compared with the control group (P<0.001). His therapy 
could significantly (21.77% and 18.86%, respectively) 
mitigate the increment of FBS and HOMA-IR in the 
HTD group compared with the UTD group (P=0.03 and P=0.03, respectively). Moreover, His therapy could 
significantly (10.48%) increase the level of insulin in the 
HTD group compared with the UTD group (P=0.04). 
Table 2 also indicates the status of lipid profile and CRR ratios. The levels of Chol, TG, LDL, VLDL, CRR 1 
and 2 significantly (1.37-fold, 1.65-fold, 7.24-fold, 1.65-
fold, 2.77-fold and 15.30-fold, respectively) enhanced 
in the UTD group compared with the control group (P≤0.001). His treatment could remarkably (18.26%, 
36.12%, 40.22%, 36.12%, 41.96% and 57.28%, 
respectively) reduce the parameters above in the HTD 
group compared with the UTD group (P=0.01, P<0.001, 
P=0.002, P<0.001, P<0.001, P<0.001 and P<0.001, 
respectively). A significant decline (2-fold) in the serum 
level of HDL-C was observed in the UTD group compared 
with the control group (P<0.001). Treatment with His 
could significantly (40.71%) augment the serum HDL-C 
level in the HTD group compared with the UTD group (P<0.001).   The serum levels of UA and Cr, as the renal functional 
markers, have been indicated in Table 2. A significant 
increment (1.76-fold and 1.25-fold, respectively) in 
the levels of UA and Cr was detected in the UTD group 
compared with the control group (P=0.007 and P=0.01, 
respectively). Treatment with His significantly (49.79% 
and 17.33%, respectively) inhibited the increment of 
serum UA and Cr in the HTD group compared with the 
UTD group (P=0.002 and P=0.008, respectively). His could improve the levels of renal functional markers, so 
that the levels of UA and Cr in the HTD group reached the normal levels observed in controls (P>0.05).  The effect of His on the levels of MDA in sera, the 
kidney, and liver have been indicated in Figure 1. MDA 
levels in serum, the kidney, and liver of the UTD group 
significantly augmented (3.17-fold, 1.38-fold, and 1.63-
fold, respectively) in comparison with the control group (P<0.001, P=0.02 and P<0.001, respectively). In the HTD 
group, His could significantly (25.53% and 22.03%, 
respectively) reduce the level of MDA in serum and 
the kidney compared against the UTD group (P=0.02 and P=0.04, respectively). There was no significant difference in the level of liver MDA between HTD and 
UTD groups (P>0.05). The levels of GSH in serum, the kidney, and liver in 
Table 2. The effects of His on the levels of FBS, insulin, HOMA-IR, lipid profile & CRRs (TG, Chol, LDL, VLDL, HDL-C, CRR 1 and 2) and renal 
functional markers (UA & Cr) in control, UTD, and HTD groups
 
2 
 
 
Parameter Control UTD HTD 
FBS (mg/dl)  104.83±5.99 288.00±29.01* 225.28±4.15*# 
Insulin (μg/l)  1.75±0.04 1.43±0.04* 1.58±0.03*# 
HOMA-IR 0.44±0.02 1.06±0.03* 0.86±0.06*# 
Chol (mg/dl)  65.46±1.55 89.92±4.47* 73.50±3.94# 
TG(mg/dl)  61.20±2.9 101.45±5.01* 64.80±3.95# 
HDL-C (mg/dl)  46.83±0.6 23.36±0.54* 32.87±0.85*# 
LDL (mg/dl)  6.39±1.76 46.27±4.38* 27.66±3.39*# 
VLDL (mg/dl)  12.24±0.58 20.29±1.00* 12.96±0.79# 
CRR1 (TC/HDL-C)  1.39±0.03 3.86±0.20* 2.24±0.14*# 
CRR2 (LDL/HDL-C)  0.13±0.03 1.99±0.19* 0.85±0.11*# 
UA (mg/dl)  1.41±0.27 2.49±0.31* 1.25±0.09# 
Cr (mg/dl)  0.60±0.02 0.75±0.03* 0.62±0.02# 
  
* Shows significant difference against the control group; # Shows significant difference against the UTD group
FBS: Fasting Blood Sugar, HOMA-IR: Homeostatic Model Assessment for Insulin Resistance, Chol: Cholesterol, TG: Triglyceride, HDL-C: High Density Lipoprotein Cholesterol, LDL: Low Density Lipoprotein, VLDL: Very Low Density Lipoprotein, CRR 1: Cardiac Risk Ratio 1, CRR 2: Cardiac Risk Ratio 2, UA: Uric Acid, Cr: Creatinine, UTD: Untreated Diabetic, HTD: His-Treated Diabetic
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the three groups are indicated in Figure 1. GSH levels in 
serum, the kidney, and liver were significantly reduced 
(1.86-fold, 1.73-fold, and 1.87-fold, respectively) in 
the UTD group in comparison with the control group (P<0.001). In the HTD group, His could significantly 
(45.07%, 60.88%, and 50.19%, respectively) enhance GSH levels in serum, the kidney, and liver compared 
with the UTD group (P=0.01, P<0.001, and P<0.001, 
respectively). There was no significant difference in the level of the kidney GSH between the HTD and UTD 
groups (P>0.05). The activities of CAT in serum, the kidney, and liver 
have been indicated in Figure 1. CAT activities in serum, 
the kidney, and liver were significantly (1.74-fold, 2.01-
fold, and 2.56-fold, respectively) lower in the UTD 
group compared with the control group (P<0.001). It 
was observed that there were no significant differences in the activities of CAT in serum, the kidney, and liver between the His treated rats and the untreated rats with T2D (P=0.38, P=0.93, and P=0.39, respectively).  Total SOD activities in serum, the kidney, and liver 
have been shown in Figure 1. Total SOD activities in serum, the kidney, and liver of the UTDs were 
significantly reduced (2.46-fold, 1.44-fold, and 2.23-
fold, respectively) compared with the controls (P=0.001, 
P<0.001, and P<0.001, respectively). In the HTDs, 
His could notably (144.94%, 57.51%, and 118.90%, 
respectively) increase total SOD activities of serum, the kidney, and liver compared with the UTDs (P=0.001, 
P<0.001, and P<0.001, respectively). 
GPX activities in serum, the kidney, and liver are 
indicated in Figure 1. Serum, renal, and liver activities 
of GPX in the UTD group were significantly less (2.37-
fold, 1.37-fold, and 1.48-fold, respectively) than those of 
the control group (P<0.001). The activities of GPX in the 
HTD group were significantly higher (40.65%, 60.88%, 
and 32.22%, respectively) than those of the UTD group (P=0.002, P<0.001, and P<0.001, respectively). 
MPO activity in the kidney and liver of the UTD group 
(Figure 1) significantly enhanced (3.11-fold and 5.22-
fold, respectively) in comparison with the control group (P=0.002 and P<0.001, respectively). In the HTD group, 
MPO activity was significantly (63.26%) decreased in 
the kidney compared with the UTD group (P=0.002). 
There was no significant difference in the activity of 
liver MPO between UTD and HTD groups (P=0.38).
The level of serum NO has been indicated in Figure 1. 
The serum level of NO in the UTD group was significantly 
higher (3.17-fold) than that the control group (P<0.001). 
His could significantly (25%) reduce NO concentration in the serum of the HTDs compared with the UTDs (P=0.01).
Histological study
The results of the histological evaluation of PAS 
stained kidney sections have been shown in Figures 2 
and 3. Glomerular volume, glomerular sclerosis, and 
leukocyte infiltration in the UTD group significantly 
increased compared with the control group (P<0.001). 
Treatment with His could significantly reduce the 
aforementioned parameters in the HTD group compared 
with the UTD group (P<0.001).
 
1 
 
 
Figure 1. The effects of His therapy on oxidative stress biomarkers including A) MDA, B) Total SOD, C) GSH, D) GPX, E) CAT, F) MPO, and G) NO in 
different groups. Data are represented as Mean ±SE. * Shows significant difference against the control group; # Shows significant difference against 
the UTD group
MDA: Malondialdehyde, GSH: Glutathione, CAT: Catalase, GPX: Glutathione Peroxidase, SOD: Superoxide Dismutase, NO: Nitric Oxide, MPO: Myeloperoxidase, UTD: Untreated Diabetic, HTD: His-Treated Diabetic
 
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. A) Glomerular volume, B) Level of glomerular sclerosis, and C) Level of leukocyte infiltration in different groups. Data are represented as 
Mean ±SE. *Shows significant difference against the control group. #Shows significant difference against the UTD group UTD: Untreated Diabetic, HTD: His-Treated Diabetic
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Gene expression study
The status of Cu-Zn SOD, GPX, and TNF-α gene 
expressions in the UTD and HTD groups compared 
with the control group have been indicated in Figure 
4, and Tables 3 and 4. A significant increase in the 
mRNA expression levels of Cu-Zn SOD, GPX, and TNF-α 
was observed in the UTD group in comparison with 
the control group (P=0.008, P=0.012, and P=0.002, 
respectively). In the HTD group, His therapy could 
restore the mRNA expression of Cu-Zn SOD and GPX to their normal expression levels, so that their expressions 
did not significantly differ from those in the control 
group (P=0.91 and P=0.44, respectively). Furthermore, 
His therapy significantly reduced TNF-α mRNA 
 
3 
 
 
 
 
A B C 
Figure 3. The effects of His therapy on renal histopathological parameters observed in the photomicrographs of kidney sections stained with PAS. 
A) Micrograph (400×) from the kidney of an animal in the control group demonstrated normal glomeruli and tubules. B) Micrograph (400×) from 
the kidney of a diabetic untreated animal demonstrated glomerulosclerosis (Score 3) and lymphocyte infiltration. C) Micrograph (400×) from the 
kidney of a diabetic animal treated with His demonstrated glomerulosclerosis (Score 1) with low level of lymphocyte infiltration 
PAS: Periodic Acid-Schiff, His: Histidine 
4 
 
 
 Figure 4. A) Box plot indicates renal gene expression ratio of Cu-Zn SOD, GPX, and TNF-α, in the UTD group. B) Box plot indicates renal gene expression ratio of Cu-Zn SOD, GPX, and TNF-α in the HTD group. Boxes represent the interquartile range or the middle 50% of observations. The 
dotted line represents the median gene expression. Whiskers represent the minimum and maximum observations. C) Agarose gel electrophoresis 
(1%) of real time-PCR amplification of β-actin, Cu-Zn SOD, GPX, and TNF-α 
β-actin: Beta-actin,  (Cu-Zn) SOD: Cu-Zn Superoxide Dismutase, GPX: Glutathione Peroxidase, TNF-α: Tumor Necrosis Factor Alpha, UTD: Untreated Diabetic, HTD: His-Treated Diabetic
 
3 
Gene Type Reaction efficiency Expression Std. Error 95% C.I. P(H1) Result 
β-actin 
 REF 0.7663 1.000     
Cu-Zn SOD 
 TRG 0.7813 6.392 3.808 - 13.108 3.160 - 15.333 0.008 UP 
GPX 
 TRG 0.7813 4.721 2.049 - 8.303 1.654 - 10.252 0.012 UP 
TNF-α TRG 0.8075 91.592 46.152 - 153.749 37.888 - 166.887 0.002 UP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Output data from Rest-RG software revealed the level of renal gene expression of Cu-Zn SOD, GPX, and TNF-α between control and UTD 
groups. The level of significant difference against the control group was set at P-value<0.05
P(H1): Probability of alternative hypothesis that difference between untreated diabetic and control groups is due only to chance
TRG: Target; REF: Reference β-actin: Beta-actin, (Cu-Zn) SOD: Cu-Zn Superoxide Dismutase, GPX: Glutathione Peroxidase, TNF-α: Tumor Necrosis Factor Alpha
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expression in the HTD group in comparison with the 
control group (P=0.02).
Discussion
The ameliorative effects of eight-week His therapy on diabetic complications in STZ/NA-induced type 2 diabetic rats have been indicated in the present 
study. Treatment with His significantly diminished 
hyperglycemia, insulin resistance, and increment of renal functional markers, inhibited oxidative stress 
and inflammation, ameliorated lipid profile and insulin 
secretion, and finally reversed renal histological 
alterations and gene expressions in STZ/NA-induced type 2 diabetic rats.   
The beneficial effects of amino acids in the 
management of hyperglycemia have been highlighted in 
certain studies (14, 28). In the present study, we similarly 
found that His therapy could mitigate FBS in the rats 
with T2D. Moreover, the hypoglycemic effect of His has been reported in STZ-induced diabetic rats under His or 
carnosine therapy (19). Additionally, the hypoglycemic 
property of some amino acids, including glycine (Gly) 
(14), cysteine (Cys) (28), isoleucine (Ile) (29), and 
lysine (Lys) (15) have been reported in vivo. A published 
paper indicated that His hypoglycemic action was linked to the impression on the central nervous system 
(CNS), motivation of signal transducer and activator of 
transcription 3 (STAT3) pathway, and diminution of the 
gene expression of gluconeogenic enzymes in the livers 
of mice (30). Confirming the results of previous studies, 
the present research exhibits the beneficial effects of 
amino acids in the management of hyperglycemia. The exhibition of the useful effects of His on insulin sensitivity in rats with T2D in this research approves 
previous studies indicating the increment of insulin 
sensitivity by amino acids, including His (16, 28). Furthermore, it was reported that insulin resistance is associated with decreased His levels in the plasma, liver, 
and skeletal muscles in Zucker diabetic fatty rats (31). 
According to data obtained from the determination of insulin level and HOMA-IR, it could be concluded that 
in addition to the mechanism affecting CNS which was 
reported previously, the hypoglycemic effect of His in 
rats with T2D might be associated with the improved 
beta cell function. This hypothesis confirms the anti-
oxidant and anti-inflammatory characteristics of His 
and its function regarding the reduced insulin resistance homeostatic model assessment for insulin resistance 
(HOMA-IR) (16). 
Our results also indicated that the serum levels of Chol, TG, LDL, VLDL, CRR 1, and CRR 2 increased, and 
HDL-C decreased in type 2 diabetic rats. The changes in these parameters are similar to the previous reports 
(19, 28, 32). In the HTD group, His could significantly reverse the aforementioned parameters. Moreover, 
hypolipidemic effects of His have been highlighted in the elderly and the animal model of hepatic steatosis 
in mice (33-35). Furthermore, the hypolipidemic 
effects of other amino acids such as glutamine (Gln), 
aspartic acid (ASP), arginine (Arg), glutamic acid (Glu), Cys, and Lys have been previously reported (15, 28, 
36). The mechanism of the hypolipidemic effect of His 
might be due to its role in the reduction of activity and mRNA expression of malic enzyme, fatty acid synthase, 
β-hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase, 
and sterol regulatory element-binding proteins (SREBP) 
(33). Our results revealed that the serum levels of Cr and UA 
significantly increased in type 2 diabetic group versus 
the control group similar to previous studies (37). His 
could significantly diminish the levels of serum Cr and UA in the treated type 2 diabetic rats in comparison with 
the untreated type 2 diabetic rats. The beneficial effects 
of some amino acids such as His, L-Gln, and Arg on the renal function have also been reported in published 
papers (36, 38, 39). The improvement of serum Cr and 
UA in the HTD group might be due to His effects in the 
increment of GFR. Unfortunately, collecting enough urine for GFR measurement was one of our limitations.
Hyperglycemia leads to the impairment of various 
organs and tissues in DM. That is, hyperglycemia not 
only leads to ROS generation but also suppresses 
the antioxidant system through the glycation of anti-
oxidant enzymes (8). The diminution of anti-oxidant enzyme activities could cause the surplus accessibility of superoxide anion and H2O2, and also could trigger 
LPO (40). In the present study, the significant lowering 
in GSH levels and CAT, total SOD and GPX activities, and 
the significantly increased MDA levels, as the marker 
of LPO, in various organs of diabetic rats approve the 
augmented oxidative stress induced by hyperglycemia. 
These findings were similar to previous studies (41, 
42). Anti-oxidant effects of His have also been indicated 
in obese women (16), animal model of DM (19), liver 
damages (43), and Cu-induced oxidative stress (17). Similarly, in our study, His therapy in diabetic animals 
could enhance the activities of total SOD, GPX, and GSH, 
and reduce serum and kidney LPO. The recovery of anti-
Table 4. Output data from Rest-RG software revealed the level of renal gene expression of Cu-Zn SOD, GPX, and TNF-α between control and HTD 
groups. The level of significant difference against the control group was set at P-value<0.05
 
4 
 
Gene Type Reaction efficiency Expression Std. Error 95% C.I. P(H1) Result 
β-actin REF 0.775 1.000     
Cu-Zn SOD TRG 0.7538 0.972 0.544 - 1.919 0.376 - 2.942 0.914 NSD 
GPX TRG 0.8 1.407 0.765 - 3.316 0.329 - 4.402 0.446 NSD 
TNF-α TRG 0.7813 0.019 0.010 - 0.038 0.006 - 0.054 0.028 DOWN 
P(H1): Probability of alternative hypothesis that difference between histidine treated and control groups is due only to chance; TRG: Target; REF: 
Reference; NSD: No significant difference; β-actin: Beta-actin, (Cu-Zn) SOD: Cu-Zn Superoxide Dismutase, GPX: Glutathione Peroxidase, TNF-α: Tumor Necrosis Factor Alpha
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oxidant enzyme activities and GSH levels by His might 
neutralize free radicals and subsequently suppress 
reactions leading to LPO (42).  
Diabetic nephropathy (DN) is one of the prevalent 
diabetic complications in the progressive stage of DM. 
Renal histopathological alterations typically occur in 
DN including increment in the thickness of glomerular 
basement membrane, mesangial expansion, and 
glomerulosclerosis (44). In the UTD group, a significant 
increase in mean glomerular volume, glomerular 
sclerosis, and leukocyte infiltration clearly approved diabetes-induced kidney injuries.  
It has been suggested that endothelial dysfunction 
(ED) plays a pivotal role in the pathogenesis of DN (45). 
Myeloperoxidase is proposed as a significant marker 
for the prediction of ED in patients with T2D (46). Myeloperoxidase decreases the bioavailability of NO and ultimately leads to ED and instability of atherosclerotic 
plaques (47). Hence, it is a good marker for ED and 
inflammation. In the present study, increased renal 
and liver MPO activities in the UTD group indicated 
enhanced inflammation and risk of ED and renal injuries, 
which were approved by our histological findings. His 
therapy significantly reduces renal histopathological 
damages and renal MPO activity. Confirming the results of previously published papers, this research indicates the renoprotective effects of amino acids such as L-Gln 
and Arg (38, 39). 
It is widely acknowledged that STZ-induced diabetes 
triggers an augment in the activity and expression of 
inducible nitric oxide synthase (iNOS) as the generator 
of NO (48). In published data, increased iNOS activity 
and NO level, as the consequences of inflammatory 
progression, were related to DN (39, 49). Similarly, elevated serum NO was found in our study. The interaction between NO and the superoxide anion leads 
to nitrosative stress and peroxynitrite generation as 
an offensive cellular oxidant (50). His therapy could 
significantly reduce NO levels in diabetic animals similar 
to previously published data revealing the beneficial effects of amino acids on NO and nitrosative stress (39, 
51). 
It has been proven that TNF-α can participate in the 
pathogenesis of DN through different mechanisms. 
Some researchers have proposed that pro-inflammatory 
cytokines, including TNF-α and IL-6, are related to the 
frequency and intensity of DN (12). In the present study, 
DM significantly up-regulated TNF-α mRNA expression 
compared with the control group. In this regard, different studies have demonstrated that DN is associated with the disorders in the balance of cytokines such as 
amplified TNF-α gene expression (52). His therapy could 
significantly down-regulate TNF-α mRNA expression in the treated diabetic rats versus the control rats in this 
study. Similarly, the anti-inflammatory effect of His 
through down-regulation of TNF-α mRNA expression 
was reported in mice with colitis (53). The suppressive 
effects of His on TNF-α expression might be associated 
with the NF-κB-signaling pathway. Due to its potential 
function in regulating the transcription process of 
different cytokines, His might suppress the activation of 
nuclear factor-κB (NF-κB) and subsequently inhibit the 
generation of pro-inflammatory cytokines (53).  
Renal GPX gene expression was significantly up-
regulated in the UTD group compared with the control 
group. However, renal GPX activity was significantly 
reduced in the UTD group. A significant increment in 
renal GPX mRNA expression that was observed in the 
UTD group seems to be conquering the decline of GPX activity. Moreover, similar results were reported by 
other studies (54, 55). His therapy could decrease the 
renal GPX mRNA expression, and increase its activity in 
a way that their levels were not significantly different 
from those in the control group (P>0.05). According 
to these data, the rise of renal GPX activity induced by 
His might be associated with its effects on the levels of translation and/or post-translational mechanisms. 
Previous studies ascribed the decline in GPX activity 
in diabetic rats to post-translational proceedings. 
Decreased activity might be associated with diabetes-induced oxidative stress and dephosphorylation (54, 
56).   
Renal Cu-Zn SOD gene expression significantly up-
regulated in the UTD group compared with the control 
group, while total kidney SOD activity significantly reduced. Similar results were reported by other 
researchers (58). The possibility of dwindled activity and/or mRNA expression of Mn-SOD enzyme for the decline in total SOD activity should not be discounted. 
Moreover, the post-translational glycation induced 
SOD inactivation must be considered (57). Indeed, determination of activity and mRNA expression of renal Mn-SOD could clarify the reason for the declined total kidney SOD activity in type 2 diabetic rats. His therapy could lessen renal Cu-Zn SOD mRNA expression, and at 
once augment total kidney SOD activity, so that their 
levels were not significantly different from those in the 
control group (P>0.05). Based on these results, increased 
total kidney SOD activity might be associated with His effects on the translation and/or post-translational 
events for Cu-Zn SOD. Moreover, it might be associated 
with His effects on gene expression and/or translation and/or post-translational events for Mn-SOD. 
Conclusion
Our biochemical, molecular, and histological evaluations indicated that His could ameliorate diabetic 
complications, including hyperglycemia, dyslipidemia, and DN in type 2 diabetic rats. These ameliorative effects could be related to the improvement of insulin resistance, suppression of oxidative stress and 
inflammation through mitigation of LPO, restoration 
of anti-oxidant enzymes (activity & mRNA), and the 
decreased TNF-α mRNA level and MPO activity. The results of the present study revealed that due to its 
anti-oxidant and anti-inflammatory properties, His 
could ameliorate hyperglycemia, insulin resistance and 
secretion, dyslipidemia, oxidative stress, inflammation, and DN in the animal model of T2D. Hence, the use of His is recommended for diabetic patients in order to reduce diabetes complications.
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